Ami M. Kabadi

发表

RNA-guided gene activation by CRISPR-Cas9-based transcription factors

Christopher M. Vockley, Timothy E. Reddy, G. Crawford, 2013, Nature Methods.

Highly Specific Epigenome Editing by CRISPR/Cas9 Repressors for Silencing of Distal Regulatory Elements

Timothy E. Reddy, G. Crawford, Lingyun Song, 2015, Nature Methods.

Engineering synthetic TALE and CRISPR/Cas9 transcription factors for regulating gene expression.

C. Gersbach, Ami M. Kabadi, 2014, Methods.

Multiplex CRISPR/Cas9-based genome engineering from a single lentiviral vector

Charles A. Gersbach, Isaac B. Hilton, C. Gersbach, 2014, Nucleic acids research.

A CRISPR/Cas9-Based System for Reprogramming Cell Lineage Specification

Charles A. Gersbach, HaYeun Ji, C. Gersbach, 2014, Stem cell reports.

Incomplete MyoD-induced transdifferentiation is associated with chromatin remodeling deficiencies

Lee E. Edsall, R. Gordân, G. Crawford, 2017, bioRxiv.

Facile synthesis of substituted trans-2-arylcyclopropylamine inhibitors of the human histone demethylase LSD1 and monoamine oxidases A and B.

David M. Gooden, Julie A. Pollock, Ami M. Kabadi, 2008, Bioorganic & medicinal chemistry letters.

Multiplex CRISPR/Cas9-Based Genome Editing for Correction of Dystrophin Mutations that Cause Duchenne Muscular Dystrophy

William H. Majoros, William H Majoros, Timothy E Reddy, 2015, Nature Communications.

Applications of Functional Genomics for Drug Discovery

C. L. Frank, Ami M. Kabadi, L. Drowley, 2020, SLAS discovery : advancing life sciences R & D.

Epigenome editing of the CFTR-locus for treatment of cystic fibrosis.

Ian C. McDowell, Timothy E. Reddy, S. Randell, 2021, Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society.

Enhanced MyoD-Induced Transdifferentiation to a Myogenic Lineage by Fusion to a Potent Transactivation Domain

Christopher M. Vockley, Timothy E. Reddy, F. Guilak, 2014, ACS synthetic biology.

Correction of Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients Through Genomic Excision of Exon 51 by Zinc Finger Nucleases

William H. Majoros, Timothy E. Reddy, P. Thakore, 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

Reading Frame Correction by Targeted Genome Editing Restores Dystrophin Expression in Cells From Duchenne Muscular Dystrophy Patients

Charles A Gersbach, Olivier Fedrigo, P. Thakore, 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

Erratum: Reading Frame correction by targeted genome editing restores dystrophin expression in cells from duchenne muscular dystrophy patients (Molecular Therapy (2013) 21 (1718-1726) DOI: 10.1038/mt.2013.111)

P. Thakore, C. Gersbach, V. Mouly, 2013 .

AAV-based CRISPR-Cas9 genome editing: challenges and engineering opportunities

M. K. Mejía-Guerra, C. Gersbach, Ami M. Kabadi, 2023, Current Opinion in Biomedical Engineering.